Skip to content
Amyl Therapeutics
-
Amyl Therapeutics raises US$9.4M to advance amyloid disease treatment toward clinical development
Amyl Therapeutics will expand its laboratory facilities at the LegiaPark life sciences campus in Liège, Belgium, to accommodate its growing research programme.